Curon’s Secca System For Fecal Incontinence Receives 510(k) Clearance

Curon Medical's 12 sales reps will market the Secca system for the treatment of fecal incontinence. FDA 510(k) clearance was announced March 25

More from Archive

More from Medtech Insight